Mach7 Technologies (ASX:M7T)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Health Check: For ASX biotechs, the business of America remains business
ASX medtechs at the forefront of precision, safety and efficiency in healthcare
Health Check: Investors catch a falling knife as biotech big names bounce from lows
Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
Scott Power: ASX healthcare stocks fall in ‘worst reporting season for a long time’
Middle East healthcare expansion opens doors for ASX stocks
Health Check: Fisher & Paykel Healthcare shares tumble after Trump tariff king-hit
Scott Power: Mach7 launches $5M buyback, reconfirms guidance
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidance
Five ASX healthcare companies poised for game-changing catalysts
ASX imaging stocks target lucrative US veterans health market
Scott Power: Which company dropped 30pc on its latest quarterly result?
